October 1, 2024 – Talk Bio

Prime Medicine, Bristol Myers Squibb (BMS), Cell Therapy, Gene Editing, Prime Editing, PASSIGE Technology, Ex Vivo T-Cell Therapies, Pipeline Reprioritization, Strategic Collaboration

Federal Judge Dismisses $6.4 Billion Lawsuit Against Bristol Myers Squibb Over Celgene Acquisition

7 months ago talkbio0Tagged BMS, Burning Mouth Syndrome, Celgene Acquisition, CVR, Drug Industry, federal, Judge, Legal Dispute, Myers, squibb

Bristol Myers Squibb (BMS), Celgene Acquisition, $6.4 Billion Lawsuit, Contingent Value Rights (CVR), Federal Judge Ruling, Pharmaceutical Industry, Legal Dispute

Enanta Pharmaceuticals Achieves Breakthrough in RSV Treatment with EDP-323, Demonstrating Significant Reductions in Viral Load and Symptoms

7 months ago talkbio0Tagged Alleviation, antiviral treatment, EDP-323, Enanta, Human Challenge Study, phase 2a, Respiratory syncytial virus, Symptoms, Viral Load result

Enanta Pharmaceuticals, EDP-323, Respiratory Syncytial Virus (RSV), Antiviral Treatment, Phase 2a Human Challenge Study, Viral Load Reduction, Symptom Alleviation

Rivus Pharmaceuticals Unveils Promising Phase 2a Results for HU6 in Obesity-Related Heart Failure Patients

7 months ago talkbio0Tagged cardiometabolic diseases, CMAs, fat-selective weight loss, HU6, Mitochondria, obesity-related heart failure, Rivus Pharmaceuticals, uncoupling

HU6, Rivus Pharmaceuticals, obesity-related heart failure, fat-selective weight loss, controlled metabolic accelerators (CMAs), mitochondrial uncoupling, cardiometabolic diseases.

UK Regulator Approves Pharming’s Joenja for Rare Immune Disorder APDS, Leveraging FDA Review

7 months ago talkbio0Tagged APDS, Approved, Immune System Diseases, Infrequent, Joenja, leniolisib, Medicines And Healthcare Products Regulatory Agency, Molecular Farming, pamidronate, Review [Publication Type], United States Food and Drug Administration

Joenja, leniolisib, APDS, MHRA approval, FDA review, rare immune disorder, Pharming